I'm a HCP or ORDM

936X874 Disclosure

What do you need to know?

All ABPI members and any pharmaceutical company that follows ABPI's Code of Practice for the Pharmaceutical Industry are required to disclose certain transfers of value​ - payments and other benefits in kind made to doctors, nurses, pharmacists and other health professionals and relevant decision makers. 

Why is it important for HCPs to disclose?

The disclosure of certain payments and benefits in kind is about bringing further transparency to the relationship between the pharmaceutical industry and the healthcare professionals and organisations it works with. It is a relationship that is critical to the future of medical innovation and patient care and as such, should meet the high expectations of patients and wider stakeholders.​

In its guidance Managing conflicts of interest in the NHS​, NHS England recommends that NHS organisations should 'seek to ensure that staff who are subject to wider transparency initiatives such as the ABPI Disclosure UK scheme are aware of and comply with them'.

The Academy of Medical Royal Colleges (AoMRC) also ‘recommends that all doctors support pharmaceutical disclosure via Disclosure UK and the industry’s Code of Practice‘ in its published statement, Academy reaffirms commitment to transparency in relationships with industry.

Does disclosure affect your rights?

Individuals have certain rights under the data protection laws and can raise objections about data published under their name on Disclosure UK at any time.

Related content in this section:

Last modified: 31 October 2024

Last reviewed: 31 October 2024